Triple comorbid trajectories of tobacco, alcohol, and marijuana use as predictors of antisocial personality disorder and generalized anxiety disorder among urban adults

American Journal of Public Health

Volumn 104, Issue 8, 2014, Pages 1413-1420

  Brook, Judith S ^a   Lee, Jung Yeon ^a   Rubenstone, Elizabeth ^a   Brook, David W ^a   Finch, Stephen J ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stony Brook University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDER; ARTICLE; CANNABIS SMOKING; COMORBIDITY; DRINKING BEHAVIOR; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; STATISTICAL MODEL; STATISTICS; TOBACCO USE; UNITED STATES; URBAN POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDERS; COMORBIDITY; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; NEW YORK CITY; TOBACCO USE; URBAN POPULATION; YOUNG ADULT;

EID: 84904306800     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.301880     Document Type: Article

References (73)

1. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use and other substance use in the general population. Drug Alcohol Depend. 2001;64 (3):319-327.
2. Duhig AM, Cavallo DA, McKee SA, George TP, Krishnan-Sarin S. Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addict Behav. 2005;30(2):271-283.
3. Iglesias V, Cavada G, Silva C, Cáceres D. Consumo precoz de tabaco y alcohol como factores modificadores del riesgo de uso de marihuana [Early tobacco and alcohol consumption as modifying risk factors on marijuana use]. Rev Saude Publica. 2007;41(4):517-522.
4. Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. HHS publication (SMA) 11-4658.
5. Schulenberg JE, Merline AC, Johnston LD, O'Malley PM, Bachman JG, Laetz VB. Trajectories of marijuana use during the transition to adulthood: the big picture based on national panel data. J Drug Issues. 2005;35(2):255-279.
6. Jackson KM, Sher KJ, Schulenberg JE. Conjoint developmental trajectories of young adult substance use. Alcohol Clin Exp Res. 2008;32(5):723-737.
7. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
8. Fergusson DM, Horwood LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction. 2002;97 (9):1123-1135.
9. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSMIV disorders in the National Comorbidity Survey Replication [published erratum appears in Arch Gen Psychiatry. 2005;62(7):709]. Arch Gen Psychiatry. 2005;62(6): 617-627.
10. Milich R, Lynam D, Zimmerman R, et al. Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users. J Subst Abuse. 2000;11(1):69-88.
11. Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol. 2004;16(4):1007- 1027.
12. Huang B, Grant BF, Dawson DA, et al. Raceethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, alcohol and drug use disorders and Axis I and II disorders: United States, 2001 to 2002. Compr Psychiatry. 2006;47(4):252-257.
13. Mericle AA, Ta Park VM, Holck P, Arria AM. Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity. Compr Psychiatry. 2012;53(6):657-665.
14. Smith SM, Stinson FS, Dawson DA, Goldstein R, Huang B, Grant BF. Race/ethnic differences in the prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2006;36(7):987-998.
15. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(6):677-685.
16. Goldstein RB, Compton WM, Pulay AJ, et al. Antisocial behavioral syndromes and DSM-IV drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;90(2-3):145-158.
17. Orlando M, Tucker JS, Ellickson PL, Klein DJ. Concurrent use of alcohol and cigarettes from adolescence to young adulthood: an examination of developmental trajectories and outcomes. Subst Use Misuse. 2005;40(8):1051-1069.
18. Caldeira KM, O'Grady KE, Vincent KB, Arria AM. Marijuana use trajectories during the post-college transition: health outcomes in young adulthood. Drug Alcohol Depend. 2012;125(3):267-275.
19. Flory K, Lynam D, Milich R, Leukefeld C, Clayton R. Early adolescent through young adult alcohol and marijuana use trajectories: early predictors, young adult outcomes, and predictive utility. Dev Psychopathol. 2004;16(1):193-213.
20. Hoffman JH, Welte JW, Barnes GM. Co-occurrence of alcohol and cigarette use among adolescents. Addict Behav. 2001;26(1):63-78.
21. Schmid B, Hohm E, Blomeyer D, et al. Concurrent alcohol and tobacco use during early adolescence characterizes a group at risk. Alcohol Alcohol. 2007;42 (3):219-225.
22. Bray JW, Zarkin GA, Dennis ML, French MT. Symptoms of dependence, multiple substance use, and labor market outcomes. Am J Drug Alcohol Abuse. 2000;26(1):77-95.
23. Brook JS, Brook DW, Zhang C. Psychosocial predictors of nicotine dependence in Black and Puerto Rican young adults. Nicotine Tob Res. 2008;10(6):959-967.
24. Kann L, Kinchen SA, Williams BI, et al. Youth Risk Behavior Surveillance-United States, 1999. MMWR CDC Surveill Summ. 2000;49(5):1-32.
25. Room R. Measuring alcohol consumption in the United States: methods and rationales. In: Kozlowski LT, Annis HM, Cappell HD, et al, eds. Research Advances in Alcohol and Drug Problem. Vol 10. New York, NY: Plenum Press; 1990:39-80.
26. Brown SA, Meyer MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the customary drinking and drug use record (CDDR): a measure of adolescent alcohol and drug involvement. J Stud Alcohol. 1998;59(4):427-438.
27. Huizinga DH, Menard S, Elliot DS. Delinquency and drug use: temporal and developmental patterns. Justice Q. 1989;6(3):419-455.
28. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a selfreport symptom inventory. Behav Sci. 1974;19(1):1-15.
29. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51 (1):8-19.
30. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51 (5):355-364.
31. Muthén LK, Muthén BO. Mplus User's Guide. 4th ed. Los Angeles, CA: Muthén & Muthén; 2007.
32. Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6(2):461-464.
33. Delucchi KL, Matzger H, Weisner C. Dependent and problem drinking over 5 years: a latent class growth analysis. Drug Alcohol Depend. 2004;74(3):235-244.
34. Dodge KA, Laird RD. A semiparametric groupbased approach to analyzing developmental trajectories in child conduct problems. Paper presented at: biennial meeting of the Society for Research in Child Development; April 1999; Albuquerque, NM.
35. Piquero AR, Monahan KC, Glasheen C, Schubert CA, Mulvey E. Does time matter? Comparing trajectory concordance and covariate association using time-based and age-based assessments. Crime Delinq. 2012;59(5):738-763.
36. Chen P, Jacobson KC. Developmental trajectories of substance use from early adolescence to young adulthood: gender and racial/ethnic differences. J Adolesc Health. 2012;50(2):154-163.
37. Lansford JE, Erath S, Yu T, Pettit GS, Dodge KA, Bates JE. The developmental course of illicit substance use from age 12 to 22: links with depressive, anxiety, and behavior disorders at age 18. J Child Psychol Psychiatry. 2008;49(8):877-885.
38. Jager J, Schulenberg JE, O'Malley PM, Bachman JG. Historical variation in drug use trajectories across the transition to adulthood: the trend toward lower intercepts and steeper, ascending slopes. Dev Psychopathol. 2013; 25(2):527-543.
39. Henry KL. Low prosocial attachment, involvement with drug-using peers, and adolescent drug use: a longitudinal examination of mediational mechanisms. Psychol Addict Behav. 2008;22(2):302-308.
40. Sampson RJ, Laub JH. A life-course view of the development of crime. Ann Am Acad Pol Soc Sci. 2005;602(1):12-45.
41. Oetting ER, Donnermeyer JF, Deffenbacher JL. Primary socialization theory: the influence of the community on drug use and deviance, III. Subst Use Misuse. 1998;33(8):1629-1665.
42. Hussong AM, Curran PJ, Moffitt TE, Caspi A, Carrig MM. Substance abuse hinders desistance in young adults' antisocial behavior. Dev Psychopathol. 2004;16(4): 1029-1046.
43. Hicks BM, Schalet BD, Malone SM, Iacono WG, McGue M. Psychometric and genetic architecture of substance use disorder and behavioral disinhibition measures for gene association studies. Behav Genet. 2011;41(4):459-475.
44. Krueger RF, Hicks BM, Patrick CJ, Carlson SR, Iacono WG, McGue M. Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum. J Abnorm Psychol. 2002;111(3):411-424.
45. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109 (40):E2657-E2664.
46. Vaeth PA, Caetano R, Ramisetty-Mikler S, Rodriguez LA. Hispanic Americans Baseline Alcohol Survey (HABLAS): alcohol-related problems across Hispanic national groups. J Stud Alcohol Drugs. 2009;70 (6):991-999.
47. Green KM, Ensminger ME. Adult social behavioral effects of heavy adolescent marijuana use among African Americans. Dev Psychol. 2006;42(6):1168-1178.
48. McFarlin SK, Fals-Stewart W. Workplace absenteeism and alcohol use: a sequential analysis. Psychol Addict Behav. 2002;16(1):17-21.
49. Bonn-Miller MO, Zvolensky MJ, Johnson KA. Unimorbid and co-occurring marijuana and tobacco use: examination of concurrent associations with negative mood states. J Addict Dis. 2010;29(1):68-77.
50. Hall W, Degenhardt L, Lynskey M. The Health and Psychological Effects of Cannabis Use. 2nd ed. Canberra: Commonwealth of Australia; 2001. Monograph Series No. 44. Available at: http://www.beckleyfoundation.org/pdf/hall- HealthAndPsychologicalEffects-2001.pdf. Accessed January 24, 2013.
51. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
52. Barry KL, Fleming MF, Manwell LB, Copeland LA. Conduct disorder and antisocial personality in adult primary care patients. J Fam Pract. 1997;45(2):151-158.
53. Eaton NR, Keyes KM, Krueger RF, et al. An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol. 2012;121(1):282-288.
54. Flynn PM, Craddock SG, Luckey JW, Hubbard RL, Dunteman GH. Comorbidity of antisocial personality and mood disorders among psychoactive substance-dependent treatment clients. J Pers Disord. 1996;10(1):56-67.
55. Moffitt TE, Caspi A, Rutter M, Silva PA. Sex Differences in Antisocial Behaviour: Conduct Disorder, Delinquency and Violence in the Dunedin Longitudinal Study. Cambridge, UK: Cambridge University Press; 2001.
56. Turner RJ, Gil AG. Psychiatric and substance use disorders in South Florida: racial/ethnic and gender contrasts in a young adult cohort. Arch Gen Psychiatry. 2002;59(1):43-50.
57. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602.
58. National Institute on Drug Abuse. Comorbidity: Addiction and Other Mental Illnesses. Bethesda, MD: National Institute on Drug Abuse; 2010. NIH publication 10-5771. Available at: http://www.drugabuse.gov/publications/ research-reports/comorbidity-addictionother-mental-illnesses. Accessed November 8, 2012.
59. Bennett S, Farrington DP, Huesmann LR. Explaining gender differences in crime and violence: the importance of social cognitive skills. Aggress Violent Behav. 2005;10 (3):263-288.
60. Caspi A, Lynam D, Moffitt TE, Silva PA. Unraveling girls' delinquency: biological, dispositional, and contextual contributions to adolescent misbehavior. Dev Psychopathol. 1993;29(1):19-30.
61. Ngun TC, Ghahramani N, Sánchez FJ, Bocklandt S, Vilain E. The genetics of sex differences in brain and behavior. Front Neuroendocrinol. 2011;32(2):227-246.
62. Burnette ML. Gender and the development of oppositional defiant disorder: contributions of physical abuse and early family environment. Child Maltreat. 2013;18(3):195-204.
63. Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants. Horm Behav. 2006;50(4):534-538.
64. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry. 1997;154 (12):1641-1647.
65. Solomon MB, Herman JP. Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiol Behav. 2009;97(2):250-258.
66. Sylvester M, Hayes SC. Unpacking masculinity as a construct: ontology, pragmatism, and an analysis of language. Psychol Men Masc. 2010;11:91-97.
67. Tieger T. On the biological basis of sex differences in aggression. Child Dev. 1980;51(4):943-963.
68. Lynskey MT, Fergusson DM, Horwood LJ. The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. J Child Psychol Psychiatry. 1998;39(7):995-1005.
69. Mennes CE, Abdallah AB, Cottler LB. The reliability of self-reported cannabis abuse, dependence and withdrawal symptoms: a multisite study of differences between general population and treatment groups. Addict Behav. 2009;34(2):223-226.
70. Alegría AA, Hasin DS, Nunes EV. Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2010;71(9):1187-1195.
71. Vida R, Brownlie EB, Beitchman JH, et al. Emerging adult outcomes of adolescent psychiatric and substance use disorders. Addict Behav. 2009;34(10):800-805.
72. Magidson JF, Liu SM, Lejuez CW, Blanco C. Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample. J Psychiatr Res. 2012;46(5):659-666.
73. Compton WM 3rd, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160(5):890-895.